Mankind Pharma

{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,406.85",
    "chg": -10.5,
    "chgp": "-0.43%",
    "dir": -1,
    "prev_price": "2,417.35",
    "mcapval": "99,401.94 Cr",
    "mcap": "Mid Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE634S01028",
    "curr_date": "Jun 22, 09:36 AM",
    "curr_time": "09:37 AM",
    "last_traded_at": "Jun 22, 09:36 AM IST",
    "bse_nse_vol": "6.57 k",
    "exc_status": "Active",
    "traded_date": "Jun 22, 2026",
    "traded_date_str": "2026 06 22",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mankind Pharma Gains 1.59%: Technical Upgrades and Strong Financials Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-gains-159-technical-upgrades-and-strong-financials-drive-momentum-4065278",
        "imagepath": "",
        "date": "2026-06-20 11:02:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Week opens at ₹2,380.60 with marginal gain</p>\n                    <p><strong>16 Jun:</strong> Stock dips 1.00% amid low volume</p>\n                    <p><strong>18 Jun:</strong> Sharp rebound with 1.75% gain following positive technical signals</p>\n                    <p><strong>19 Jun:</strong> MarketsMOJO upgrades rating to Buy; stock closes at ₹2,417.35 (+0.52%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,380.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-valu..."
      },
      {
        "title": "Mankind Pharma Ltd Upgraded to Buy by MarketsMOJO on Strong Financial and Technical Grounds",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-upgraded-to-buy-by-marketsmojo-on-strong-financial-and-technical-grounds-4062774",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_mojoScore_4062774.png",
        "date": "2026-06-19 08:17:05",
        "description": "Mankind Pharma Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its technical indicators, financial trends, valuation metrics, and overall quality. The upgrade reflects improved market sentiment, robust quarterly financials, and a bullish technical outlook, positioning the mid-cap pharmaceutical company favourably against its peers and broader market benchmarks."
      },
      {
        "title": "Mankind Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-4062705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_technicaldot_4062705.png",
        "date": "2026-06-19 08:03:46",
        "description": "Mankind Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underpinned by a combination of positive signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting an improved outlook for the mid-cap pharmaceutical player amid mixed sector and market conditions."
      },
      {
        "title": "Mankind Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-hold-by-marketsmojo-4050923",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_mojoScore_4050923.png",
        "date": "2026-06-13 10:10:36",
        "description": "Mankind Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 13 June 2026, providing investors with the most up-to-date view of the stock’s fundamentals and market performance."
      },
      {
        "title": "Mankind Pharma Gains 1.82%: 5 Key Factors Driving This Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-gains-182-5-key-factors-driving-this-weeks-momentum-4050720",
        "imagepath": "",
        "date": "2026-06-13 09:08:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 Jun:</strong> Stock opens at Rs.2,358.45, Sensex down 1.33%</p>\n                    <p><strong>9 Jun:</strong> Price rises to Rs.2,390.95 (+1.38%), Sensex rebounds +0.88%</p>\n                    <p><strong>10 Jun:</strong> Technical momentum shifts amid mixed signals; stock dips 0.80%</p>\n                    <p><strong>11 Jun:</strong> Golden Cross forms; heavy put option activity observed</p>\n                    <p><strong>12 Jun:</strong> Momentum shifts mildly bullish; stock closes at Rs.2,379.45 (+0.33%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\"..."
      },
      {
        "title": "Mankind Pharma Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicators-4048395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_technicaldot_4048395.png",
        "date": "2026-06-12 08:05:13",
        "description": "Mankind Pharma Ltd has experienced a subtle but noteworthy shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and volume-based metrics, reflecting a nuanced market sentiment for the mid-cap pharmaceutical player."
      },
      {
        "title": "Mankind Pharma Ltd Forms Golden Cross Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4047122",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_goldencross_4047122.png",
        "date": "2026-06-11 18:01:20",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Mankind Pharma Ltd, signalling a golden cross on 11 Jun 2026. Yet, the broader technical landscape presents a nuanced picture, with weekly indicators showing both bullish and mildly bearish signals, and the monthly timeframe failing to fully confirm the crossover. This divergence invites a closer examination of the signal's reliability."
      },
      {
        "title": "Rs 2,000 Puts — 16.9% Below Current Price — Draw 4,869 Contracts on Mankind Pharma Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-heavy-put-option-activity-ahead-of-june-expiry-4046721",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_most_active_stocks_puts_4046721.png",
        "date": "2026-06-11 13:00:08",
        "description": "Rs 2,000 put options on Mankind Pharma Ltd attracted 4,869 contracts on 11 Jun 2026, despite the stock trading robustly at Rs 2,405.60. This strike price sits nearly 17% below the current market price, suggesting the put activity may be more about protection than outright bearish conviction."
      },
      {
        "title": "Mankind Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4045969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_technicaldot_4045969.png",
        "date": "2026-06-11 08:05:30",
        "description": "Mankind Pharma Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early June 2026. Despite a modest decline in daily price and a downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience relative to the broader market, supported by a complex interplay of technical indicators across weekly and monthly timeframes."
      }
    ],
    "total": 537,
    "sid": "1003845",
    "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "15-Jun-2026",
      "details": "Please find attached intimation regarding participation in investor conference by management and officials of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "08-Jun-2026",
      "details": "Please find attached Intimation regarding Change in Management.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "08-Jun-2026",
      "details": "Allotment of 86778 Equity Shares under Mankind Employee Stock Option Plan 2022 (ESOP PLAN)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mankind Pharma Gains 1.59%: Technical Upgrades and Strong Financials Drive Momentum

2026-06-20 11:02:15

Key Events This Week

15 Jun: Week opens at ₹2,380.60 with marginal gain

16 Jun: Stock dips 1.00% amid low volume

18 Jun: Sharp rebound with 1.75% gain following positive technical signals

19 Jun: MarketsMOJO upgrades rating to Buy; stock closes at ₹2,417.35 (+0.52%)

Week Open

Rs.2,380.60

Week Close

Read full news article

Mankind Pharma Ltd Upgraded to Buy by MarketsMOJO on Strong Financial and Technical Grounds

2026-06-19 08:17:05

Mankind Pharma Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its technical indicators, financial trends, valuation metrics, and overall quality. The upgrade reflects improved market sentiment, robust quarterly financials, and a bullish technical outlook, positioning the mid-cap pharmaceutical company favourably against its peers and broader market benchmarks.

Read full news article

Mankind Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-19 08:03:46

Mankind Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underpinned by a combination of positive signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting an improved outlook for the mid-cap pharmaceutical player amid mixed sector and market conditions.

Read full news article

Mankind Pharma Ltd is Rated Hold by MarketsMOJO

2026-06-13 10:10:36

Mankind Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 13 June 2026, providing investors with the most up-to-date view of the stock’s fundamentals and market performance.

Read full news article

Mankind Pharma Gains 1.82%: 5 Key Factors Driving This Week’s Momentum

2026-06-13 09:08:36

Key Events This Week

8 Jun: Stock opens at Rs.2,358.45, Sensex down 1.33%

9 Jun: Price rises to Rs.2,390.95 (+1.38%), Sensex rebounds +0.88%

10 Jun: Technical momentum shifts amid mixed signals; stock dips 0.80%

11 Jun: Golden Cross forms; heavy put option activity observed

12 Jun: Momentum shifts mildly bullish; stock closes at Rs.2,379.45 (+0.33%)

Week Open

Read full news article

Mankind Pharma Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators

2026-06-12 08:05:13

Mankind Pharma Ltd has experienced a subtle but noteworthy shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and volume-based metrics, reflecting a nuanced market sentiment for the mid-cap pharmaceutical player.

Read full news article

Mankind Pharma Ltd Forms Golden Cross Amid Mixed Technical Signals

2026-06-11 18:01:20

The 50-day moving average has crossed above the 200-day moving average for Mankind Pharma Ltd, signalling a golden cross on 11 Jun 2026. Yet, the broader technical landscape presents a nuanced picture, with weekly indicators showing both bullish and mildly bearish signals, and the monthly timeframe failing to fully confirm the crossover. This divergence invites a closer examination of the signal's reliability.

Read full news article

Rs 2,000 Puts — 16.9% Below Current Price — Draw 4,869 Contracts on Mankind Pharma Ltd

2026-06-11 13:00:08

Rs 2,000 put options on Mankind Pharma Ltd attracted 4,869 contracts on 11 Jun 2026, despite the stock trading robustly at Rs 2,405.60. This strike price sits nearly 17% below the current market price, suggesting the put activity may be more about protection than outright bearish conviction.

Read full news article

Mankind Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-11 08:05:30

Mankind Pharma Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early June 2026. Despite a modest decline in daily price and a downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience relative to the broader market, supported by a complex interplay of technical indicators across weekly and monthly timeframes.

Read full news article

View All News